Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep;26(9):2222-9.
doi: 10.1681/ASN.2014070726. Epub 2015 Mar 19.

A National Study of Outcomes among HIV-Infected Kidney Transplant Recipients

Jayme E Locke  1 , Shikha Mehta  2 , Rhiannon D Reed  2 , Paul MacLennan  2 , Allan Massie  3 , Anoma Nellore  2 , Christine Durand  4 , Dorry L Segev  3
Affiliations

A National Study of Outcomes among HIV-Infected Kidney Transplant Recipients

Jayme E Locke et al. J Am Soc Nephrol. 2015 Sep.

Abstract

Kidney transplantation is a viable treatment for select patients with HIV and ESRD, but data are lacking regarding long-term outcomes and comparisons with appropriately matched HIV-negative patients. We analyzed data from the Scientific Registry of Transplant Recipients (SRTR; 2002-2011): 510 adult kidney transplant recipients with HIV (median follow-up, 3.8 years) matched 1:10 to HIV-negative controls. Compared with HIV-negative controls, HIV-infected recipients had significantly lower 5-year (75.3% versus 69.2%) and 10-year (54.4% versus 49.8%) post-transplant graft survival (GS) (hazard ratio [HR], 1.37; 95% confidence interval [95% CI], 1.15 to 1.64; P<0.001) that persisted when censoring for death (HR, 1.43; 95% CI, 1.12 to 1.84; P=0.005). However, compared with HIV-negative/hepatitis C virus (HCV)-negative controls, HIV monoinfected recipients had similar 5-year and 10-year GS, whereas HIV/HCV coinfected recipients had worse GS (5-year: 64.0% versus 52.0%, P=0.02; 10-year: 36.2% versus 27.0%, P=0.004 [HR, 1.38; 95% CI, 1.08 to 1.77; P=0.01]). Patient survival (PS) among HIV-infected recipients was 83.5% at 5 years and 51.6% at 10 years and was significantly lower than PS among HIV-negative controls (HR, 1.34; 95% CI, 1.08 to 1.68; P<0.01). However, PS was similar for HIV monoinfected recipients and HIV-negative/HCV-negative controls at both times. HIV/HCV coinfected recipients had worse PS compared with HIV-negative/HCV-infected controls (5-year: 67.0% versus 78.6%, P=0.007; 10-year: 29.3% versus 56.23%, P=0.002 [HR, 1.57; 95% CI, 1.11 to 2.22; P=0.01]). In conclusion, HIV-negative and HIV monoinfected kidney transplant recipients had similar GS and PS, whereas HIV/HCV coinfected recipients had worse outcomes. Although encouraging, these results suggest caution in transplanting coinfected patients.

Keywords: HIV nephropathy; hepatitis; kidney transplantation; outcomes.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The number of kidney transplants performed among the general ESRD population and the number of kidney transplants performed among HIV+ ESRD patients between 2002 and 2011. Since 2010 there has been a steady decline in the number of HIV+ kidney transplants performed annually.
Figure 2.
Figure 2.
GS among a matched case-controlled cohort of HIV+ and HIV− kidney transplant recipients, stratified by HCV status. (A) Monoinfected HIV+ recipients compared with HIV−/HCV− matched controls. (B) HIV+ recipients coinfected with HCV compared with HIV−/HCV+ matched controls.
Figure 3.
Figure 3.
Death censored GS among a matched case-controlled cohort of HIV+ and HIV− kidney transplant recipients, stratified by HCV status. (A) Monoinfected HIV+ recipients compared with HIV−/HCV− matched controls. (B) HIV+ recipients coinfected with HCV compared with HIV−/HCV+ matched controls.
Figure 4.
Figure 4.
PS among a matched case-controlled cohort of HIV+ and HIV− kidney transplant recipients, stratified by HCV status. (A) Monoinfected HIV+ recipients compared with HIV−/HCV− matched controls. (B) HIV+ recipients coinfected with HCV compared with HIV−/HCV+ matched controls.
See this image and copyright information in PMC

Comment in

References

    1. Centers for Disease Control and Prevention: HIV in the United States: At a glance, 2013; http://www.cdc.gov/hiv/statistics/basics/ataglance.html. Accessed June 9, 2014
    1. Palella FJ, Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD, HIV Outpatient Study Investigators : Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338: 853–860, 1998 - PubMed
    1. Rao TK: Human immunodeficiency virus infection in end-stage renal disease patients. Semin Dial 16: 233–244, 2003 - PubMed
    1. Ando M, Tsuchiya K, Nitta K: How to manage HIV-infected patients with chronic kidney disease in the HAART era. Clin Exp Nephrol 16: 363–372, 2012 - PubMed
    1. Blumberg EA, Stock P, AST Infectious Diseases Community of Practice : Solid organ transplantation in the HIV-infected patient. Am J Transplant 9[Suppl 4]: S131–S135, 2009 - PubMed

Publication types

MeSH terms